Published in PLoS One on May 01, 2015
The vitronectin RGD motif regulates TGF-β-induced alveolar epithelial cell apoptosis. Am J Physiol Lung Cell Mol Physiol (2016) 0.78
p53- and PAI-1-mediated induction of C-X-C chemokines and CXCR2: importance in pulmonary inflammation due to cigarette smoke exposure. Am J Physiol Lung Cell Mol Physiol (2016) 0.78
Aberrant coagulation causes a hyper-inflammatory response in severe influenza pneumonia. Cell Mol Immunol (2016) 0.78
Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2016) 0.77
Regulation of p53-mediated changes in the uPA-fibrinolytic system and in lung injury by loss of surfactant protein-C expression in alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol (2017) 0.75
Plasminogen activator inhibitor-1 does not contribute to the pulmonary pathology induced by acute exposure to ozone. Physiol Rep (2016) 0.75
SERPINE1 -844 and -675 polymorphisms and chronic obstructive pulmonary disease in a Chinese Han population. J Int Med Res (2016) 0.75
The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst (1981) 25.60
Cigarette smoking and infection. Arch Intern Med (2004) 5.04
Effects of cigarette smoke on the immune system. Nat Rev Immunol (2002) 4.38
The plasminogen activator/plasmin system. J Clin Invest (1991) 4.20
Isolation and primary culture of murine alveolar type II cells. Am J Respir Cell Mol Biol (1996) 3.77
Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J Clin Invest (1996) 2.97
Possible mechanisms of emphysema in smokers. In vitro suppression of serum elastase-inhibitory capacity by fresh cigarette smoke and its prevention by antioxidants. Am Rev Respir Dis (1978) 2.90
Isolation and culture of alveolar type II cells. Am J Physiol (1990) 2.71
The impact of COPD on lung health worldwide: epidemiology and incidence. Chest (2000) 2.20
Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Crit Care Med (2003) 1.99
GM-CSF in the lung protects against lethal influenza infection. Am J Respir Crit Care Med (2011) 1.83
Cytotoxic effects of cigarette smoke extract on an alveolar type II cell-derived cell line. Am J Physiol Lung Cell Mol Physiol (2001) 1.71
Cytokine-mediated Bax deficiency and consequent delayed neutrophil apoptosis: a general mechanism to accumulate effector cells in inflammation. Proc Natl Acad Sci U S A (1999) 1.56
Structural emphysema does not correlate with lung compliance: lessons from the mouse smoking model. Exp Lung Res (2005) 1.48
Influenza virus infection increases p53 activity: role of p53 in cell death and viral replication. J Virol (2005) 1.47
Cigarette smoke worsens lung inflammation and impairs resolution of influenza infection in mice. Respir Res (2008) 1.46
Plasma levels of a specific inhibitor of tissue-type plasminogen activator (and urokinase) in normal and pathological conditions. Thromb Res (1984) 1.46
The ribonuclease A superfamily of mammals and birds: identifying new members and tracing evolutionary histories. Genomics (2005) 1.43
Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema. Int J Tuberc Lung Dis (2008) 1.41
Cigarette smoke-induced emphysema in A/J mice is associated with pulmonary oxidative stress, apoptosis of lung cells, and global alterations in gene expression. Am J Physiol Lung Cell Mol Physiol (2009) 1.40
Chronic cigarette smoke causes oxidative damage and apoptosis to retinal pigmented epithelial cells in mice. PLoS One (2008) 1.40
Cigarette smoke impacts immune inflammatory responses to influenza in mice. Am J Respir Crit Care Med (2006) 1.38
RNase A ribonucleases and host defense: an evolving story. J Leukoc Biol (2008) 1.34
Exposure to cigarette smoke inhibits the pulmonary T-cell response to influenza virus and Mycobacterium tuberculosis. Infect Immun (2010) 1.31
Remodeling in response to infection and injury. Airway inflammation and hypersecretion of mucus in smoking subjects with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 1.29
PAI-1 inhibits neutrophil efferocytosis. Proc Natl Acad Sci U S A (2008) 1.27
Innate immune response to H3N2 and H1N1 influenza virus infection in a human lung organ culture model. Virology (2009) 1.19
Long-term cigarette smoke exposure in a mouse model of ciliated epithelial cell function. Am J Respir Cell Mol Biol (2009) 1.14
Production of plasminogen activator inhibitor-1 by human mast cells and its possible role in asthma. J Immunol (2000) 1.12
Inhibition of IL-18 reduces myeloperoxidase activity and prevents edema in intestine following alcohol and burn injury. J Leukoc Biol (2005) 1.10
Nrf2 protects human alveolar epithelial cells against injury induced by influenza A virus. Respir Res (2012) 1.09
The plasminogen activation system in lung disease. Curr Drug Targets (2007) 1.06
COPD performance measures: missing opportunities for improving care. Chest (2010) 1.05
Upregulation of pirin expression by chronic cigarette smoking is associated with bronchial epithelial cell apoptosis. Respir Res (2007) 1.04
Plasminogen activator inhibitor-1: the double-edged sword in apoptosis. Thromb Haemost (2008) 1.03
Regulation of plasminogen activator inhibitor-1 expression by tumor suppressor protein p53. J Biol Chem (2008) 1.03
The plasmin system in airway remodeling. Thromb Res (2003) 1.01
Respiratory health effects of passive smoking: EPA's weight-of-evidence analysis. J Clin Epidemiol (1994) 1.00
Plasminogen activator inhibitor 1 and plasminogen activator inhibitor 2 in various disease states. Thromb Haemost (1988) 0.97
Reduced spontaneous apoptosis in peripheral blood neutrophils during exacerbation of COPD. Eur Respir J (2004) 0.96
Neonatal oxygen increases sensitivity to influenza A virus infection in adult mice by suppressing epithelial expression of Ear1. Am J Pathol (2012) 0.94
Regulation of lung injury and fibrosis by p53-mediated changes in urokinase and plasminogen activator inhibitor-1. Am J Pathol (2013) 0.94
Regulation of airway and alveolar epithelial cell apoptosis by p53-Induced plasminogen activator inhibitor-1 during cigarette smoke exposure injury. Am J Respir Cell Mol Biol (2012) 0.93
Induction of tissue factor by urokinase in lung epithelial cells and in the lungs. Am J Respir Crit Care Med (2010) 0.93
Regulation of alveolar epithelial cell apoptosis and pulmonary fibrosis by coordinate expression of components of the fibrinolytic system. Am J Physiol Lung Cell Mol Physiol (2011) 0.92
Neonatal hyperoxia contributes additively to cigarette smoke-induced chronic obstructive pulmonary disease changes in adult mice. Am J Respir Cell Mol Biol (2011) 0.88
Maintenance of lung myeloperoxidase activity in proestrus females after trauma-hemorrhage: upregulation of heme oxygenase-1. Am J Physiol Lung Cell Mol Physiol (2006) 0.88
Influenza A virus infection of mice induces nuclear accumulation of the tumorsuppressor protein p53 in the lung. Arch Virol (2001) 0.87
Nicotine increases plasminogen activator inhibitor-1 production by human brain endothelial cells via protein kinase C-associated pathway. Stroke (1999) 0.86
Recovery of intraoperative microbicidal and inflammatory functions of alveolar immune cells after a tobacco smoke-free period. Anesthesiology (2001) 0.85
Plasminogen activator inhibitor-1 in the pathogenesis of asthma. Exp Biol Med (Maywood) (2004) 0.85
The effects of chronic smoking on the fibrinolytic potential of plasma and platelets. Br J Haematol (1997) 0.84
Role of the urokinase-fibrinolytic system in epithelial-mesenchymal transition during lung injury. Am J Pathol (2014) 0.83
Is smoking a risk factor for influenza hospitalization and death? J Infect Dis (2010) 0.82